|
1. Novartis CEO: Trump drug pricing impact to hit in 18 months Full story
2. AHA urges HHS to block Eli Lilly's 340B data demands: 5 things to know Full story
3. Pharmacy leaders are rethinking medication dispensing. Learn how better visibility and AI-powered insights are optimizing decisions and performance. Register here to attend the live panel.
4. FDA weighs pulling Amgen drug Full story
5. Utah medical board calls to suspend AI pilot for prescriptions Full story
6. "Enterprise operators who happen to be pharmacists." That's how the CPOs on stage at Becker's Spring 2026 Chief Pharmacy Officer Summit described the role now. Find the full briefing here.
7. 6 big pharma moves Full story
8. Employers' GLP-1 coverage dilemma grows Full story
9. FDA backs 3 psychedelic drug studies for mental illness Full story
10. Health systems reboot ambulatory investments Full story
11. Nation's largest measles outbreak in 35 years ends: 6 notes Full story
12. Payer strategies for specialty drug benefits are shifting. Inform your response with insights here.
Becker's Learning Opportunities
13. Procurement inconsistency grows with expansion. Strategies to enforce control without losing flexibility here.
14. Hospital pharmacies lose 1,984+ hours a year to controlled substance waste reviews. Learn more here.
15. Dementia detection often starts in primary care — how Advocate + others equip clinicians here.
16. Becker’s resources don’t stop here — explore more
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
